Dose reduction of bone morphogenetic protein-2 for bone regeneration using a delivery system based on lyophilization with trehalose

References

• ReddiAHBMPs: from bone morphogenetic proteins to body morphogenetic proteinsCytokine Growth Factor Rev200516324925015949967
   PubMed Web of Science ®Google Scholar
• TermaatMFDen BoerFCBakkerFCPatkaPHaarmanHJBone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defectsJ Bone Joint Surg Am20058761367137815930551
   PubMed Web of Science ®Google Scholar
• GovenderSCsimmaCGenantHKRecombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsJ Bone Joint Surg Am200284-A122123213412473698
   PubMed Web of Science ®Google Scholar
• KanakarisNKGiannoudisPVClinical applications of bone morphogenetic proteins: current evidenceJ Surg Orthop Adv200817313314618851797
   PubMedGoogle Scholar
• PoyntonARLaneJMSafety profile for the clinical use of bone morphogenetic proteins in the spineSpine20022716 Suppl 1S40S4812205419
   PubMed Web of Science ®Google Scholar
• ShieldsLBRaqueGHGlassmanSDAdverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusionSpine200631554254716508549
   PubMed Web of Science ®Google Scholar
• MontMARaglandPSBigginsBUse of bone morphogenetic proteins for musculoskeletal applications. An overviewJ Bone Joint Surg Am200486A Suppl 2415515691108
   PubMedGoogle Scholar
• JamesAWLaChaudGShenJA review of the clinical side effects of bone morphogenetic protein-2Tissue Eng Part B Rev201622428429726857241
   PubMed Web of Science ®Google Scholar
• CarrageeEJHurwitzELWeinerBKA critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learnedSpine J201111647149121729796
   PubMed Web of Science ®Google Scholar
• LewandrowskiKUNansonCCalderonRVertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five casesSpine J20077560961417526434
   PubMed Web of Science ®Google Scholar
• YangHSLaWGBhangSHJeonJYLeeJHKimBSHeparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2Tissue Eng Part A20101641225123319886733
   PubMed Web of Science ®Google Scholar
• YamamotoMTakahashiYTabataYEnhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogelTissue Eng20061251305131116771643
   PubMedGoogle Scholar
• OhSDaraioCChenLHPisanicTRFinonesRRJinSSignificantly accelerated osteoblast cell growth on aligned TiO2 nanotubesJ Biomed Mater Res A20067819710316602089
   PubMed Web of Science ®Google Scholar
• BjurstenLMRasmussonLOhSSmithGCBrammerKSJinSTitanium dioxide nanotubes enhance bone bonding in vivoJ Biomed Mater Res A20109231218122419343780
   PubMed Web of Science ®Google Scholar
• SunSYuWZhangYZhangFIncreased preosteoblast adhesion and osteogenic gene expression on TiO2 nanotubes modified with KRSRJ Mater Sci Mater Med20132441079109123371766
   PubMed Web of Science ®Google Scholar
• MaYZhangZLiuYNanotubes functionalized with BMP2 knuckle peptide improve the osseointegration of titanium implants in rabbitsJ Biomed Nanotechnol201511223624426349299
   PubMed Web of Science ®Google Scholar
• MozhaevVVMechanism-based strategies for protein thermostabilizationTrends Biotechnol199311388957763513
   PubMed Web of Science ®Google Scholar
• ArakawaTPrestrelskiSJKenneyWCCarpenterJFFactors affecting short-term and long-term stabilities of proteinsAdv Drug Deliv Rev2001461–330732611259845
   PubMed Web of Science ®Google Scholar
• WangWLyophilization and development of solid protein pharmaceuticalsInt J Pharm20002031–216010967427
   PubMed Web of Science ®Google Scholar
• AbdelwahedWDegobertGStainmesseSFessiHFreeze-drying of nanoparticles: formulation, process and storage considerationsAdv Drug Deliv Rev200658151688171317118485
   PubMed Web of Science ®Google Scholar
• GriebenowKKlibanovAMLyophilization-induced reversible changes in the secondary structure of proteinsProc Natl Acad Sci U S A1995922410969109767479920
   PubMed Web of Science ®Google Scholar
• KasperJCSchaffertDOgrisMWagnerEFriessWDevelopment of a lyophilized plasmid/LPEI polyplex formulation with long-term stability–a step closer from promising technology to applicationJ Control Release2011151324625521223985
   PubMed Web of Science ®Google Scholar
• LinsRDPereiraCSHünenbergerPHTrehalose–protein interaction in aqueous solutionProteins200455117718614997551
   PubMed Web of Science ®Google Scholar
• NetaTTakadaKHirasawaMLow-cariogenicity of trehalose as a substrateJ Dent200028857157611082525
   PubMed Web of Science ®Google Scholar
• ZhaoJWangSBaoJTrehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivoPLoS One201381e5464523359400
   PubMed Web of Science ®Google Scholar
• ZhangXZhangZShenGZhaoJEnhanced osteogenic activity and anti-inflammatory properties of Lent-BMP-2-loaded TiO2 nanotube layers fabricated by lyophilization following trehalose additionInt J Nanomedicine20161142943926869786
   PubMed Web of Science ®Google Scholar
• YuWQJiangXQZhangFQXuLThe effect of anatase TiO2 nanotube layers on MC3T3-E1 preosteoblast adhesion, proliferation, and differentiationJ Biomed Mater Res A20109441012102220694968
   PubMedGoogle Scholar
• XieGSunJZhongGLiuCWeiJHydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: absorption and release kinetics in vitroJ Mater Sci Mater Med20102161875188020300953
   PubMed Web of Science ®Google Scholar
• ZhaoJHuJWangSCombination of β-TCP and BMP-2 gene-modified bMSCs to heal critical size mandibular defects in ratsOral Dis2010161465419619194
   PubMed Web of Science ®Google Scholar
• LiBYoshiiTHafemanAENymanJSWenkeJCGuelcherSAThe effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femoraBiomaterials200930356768677919762079
   PubMed Web of Science ®Google Scholar
• RagoRMitchenJWildingGDNA fluorometric assay in 96-well tissue culture plates using Hoechst 33,258 after cell lysis by freezing in distilled waterAnal Biochem1990191131341706565
   PubMed Web of Science ®Google Scholar
• LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) MethodMethods200125440240811846609
   PubMed Web of Science ®Google Scholar
• ZhangWWangGLiuYThe synergistic effect of hierarchical micro/nano-topography and bioactive ions for enhanced osseointegrationBiomaterials201334133184319523380352
   PubMed Web of Science ®Google Scholar
• SciadiniMFJohnsonKDEvaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect modelJ Orthop Res200018228930210815831
   PubMed Web of Science ®Google Scholar
• FriessWUludagHFoskettSBironRSargeantCCharacterizaiton of absorbable collagen sponges as recombinant human bone morpho-genetic protein-2 carriersInt J Pharm19991851516010425365
   PubMedGoogle Scholar
• GinebraMPTraykovaTPlanellJACalcium phosphate cements as bone drug delivery systems: a reviewJ Control Release2006113210211016740332
   PubMed Web of Science ®Google Scholar
• HaidarZSHamdyRCTabrizianMDelivery of recombinant bone morphogenetic proteins for bone regenenration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineeringBiotechnol Lett200931121825183519690811
   PubMed Web of Science ®Google Scholar
• HuangDGLiaoSJZhouWBSynthesis of samarium- and nitrogen-co-doped TiO2 by modified hydrothermal method and its photocatalytic performance for the degradation of 4-chlorophenolJ Phys Chem Solids2009705853859
   Web of Science ®Google Scholar
• JansenJAVehofJWRuhePQGrowth factor-loaded scaffolds for bone engineeringJ Control Release20051011–312713615588899
   PubMed Web of Science ®Google Scholar
• JeonOSongSJKangSWPutnamAJKimBSEnhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly (L-lactic-co-glycolic acid) scaffoldBiomaterials200728172763277117350678
   PubMed Web of Science ®Google Scholar
• LaWGJinMParkSDelivery of bone morphogenetic protein-2 and substance P using grapheme oxide for bone regenerationInt J Nanomedicine20149Suppl 110711624872706
   PubMed Web of Science ®Google Scholar
• LaWGKangSWYangHSThe efficacy of bone morphogenetic protein-2 depends on its mode of deliveryArtif Organs201034121150115320545667
   PubMed Web of Science ®Google Scholar
• JeonOSongSJYangHSLong-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term deliveryBiochem Biophys Res Commun2008369277478018313401
   PubMed Web of Science ®Google Scholar
• UludagHGaoTPorterTJFriessWWozneyJMDelivery systems for BMPs: factors contributing to protein retention at an application siteJ Bone Joint Surg Am200183A Suppl 1S128S13511314790
   PubMedGoogle Scholar
• BoerckelJDKolambkarYMDupontKMEffects of protein dose and delivery system on BMP-mediated bone regenerationBiomaterials201132225241525121507479
   PubMed Web of Science ®Google Scholar
• QuinlanEThompsonEMMatsikoAO’BrienFJLopez-NoriegaALong-term controlled delivery of rhBMP-2 from collagen–hydroxyapatite scaffolds for superior bone tissue regenerationJ Control Release201520711211925817394
   PubMed Web of Science ®Google Scholar
• Le NihouannenDKomarovaSVGbureckUBarraletJEBioactivity of bone resorptive factor loaded on osteoconductive matrices: stability post-dehydrationEur J Pharm Biopharm200870381381818761403
   PubMed Web of Science ®Google Scholar